OSPREY PHARMACEUTICALS USA

Osprey Pharmaceuticals USA is a clinical stage company focused on the development of novel protein therapeutics for the treatment of inflammatory and immune diseases. The company is advancing a pipeline of proprietary fusion protein therapeutics known as Leukocyte Population Modulators (LPMs) that are designed to selectively target and neutralize chemokine-activated leukocytes underlying a variety of inflammatory and immune diseases. The Companyรขโฌโขs lead candidate, CCL2-LPM targeting the CCR2 chemokine receptor expressed by certain pathologically activated leukocytes is in a Phase Ib clinical trial for the treatment of IgA nephropathy.
OSPREY PHARMACEUTICALS USA
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1998-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.ospreypharma.com
Total Employee:
11+
Status:
Active
Contact:
415-352-6262
Total Funding:
28.86 M USD
Technology used in webpage:
SPF Amazon AWS Global Accelerator
Similar Organizations
Lev Pharmaceuticals
Lev Pharmaceuticals is focused on developing therapeutic products for the treatment of inflammatory diseases.
Current Advisors List
Board_member
Board_member
Investors List
GeneChem
GeneChem investment in Series A - Osprey Pharmaceuticals USA
Burrill & Company
Burrill & Company investment in Series A - Osprey Pharmaceuticals USA
Yasuda Enterprise Development
Yasuda Enterprise Development investment in Series A - Osprey Pharmaceuticals USA
Western Technology Investment
Western Technology Investment investment in Series A - Osprey Pharmaceuticals USA
Novo Nordisk
Novo Nordisk investment in Series A - Osprey Pharmaceuticals USA
BDC Venture Capital
BDC Venture Capital investment in Series A - Osprey Pharmaceuticals USA
MMV Capital Partners
MMV Capital Partners investment in Debt Financing - Osprey Pharmaceuticals USA
Reference Capital
Reference Capital investment in Venture Round - Osprey Pharmaceuticals USA
Ventures West
Ventures West investment in Venture Round - Osprey Pharmaceuticals USA
GeneChem
GeneChem investment in Venture Round - Osprey Pharmaceuticals USA
Official Site Inspections
http://www.ospreypharma.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 13.248.169.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
